Literature DB >> 2918333

Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin.

A D Turnbull1, J Guerra, H F Starnes.   

Abstract

Results of operation for obstructing carcinomatosis of gastrointestinal (GI), pancreatic, or biliary origin were reviewed to assess relief of symptoms, management of re-obstruction, and duration of hospitalization. A retrospective review (1977 to 1986) identified 89 patients, 59 (66%) of whom had tumors originating in the colon, and 19 (21%) in the stomach. Normal bowel function was restored for a median of 102 days in 66 patients (74%) and all but four (94%) were discharged. Forty-one (46%) patients remained unobstructed until death. Twenty-three (26%) were not relieved by operation and died a median of 33 days later (P less than .005). Forty-eight (81.4%) of the 59 colon cancer patients and ten (52.6%) of 19 with gastric cancer (P less than .05) were benefited by the operation, although comparison of duration of function was less striking (P less than .1). In-hospital mortality was 13% and complications occurred in 44%. Obstruction recurred in 38% of those relieved by the initial operation. Normal bowel function was restored in six (46%) of 13 patients undergoing a second laparotomy (median, 158 days) and in six of 13 (46%) treated with nasogastric suction. Obstruction recurred again in four of the latter six patients (median, 39 days). Hospitalization averaged 31 days (median, 25 days) for the first procedure and 41 days (median, 39 days) for patients operated for recurrent obstruction. These results justify laparotomy for intestinal obstruction in known or suspected carcinomatosis, particularly of colonic origin, if performance status is compatible with a reasonable quality of life.

Entities:  

Mesh:

Year:  1989        PMID: 2918333     DOI: 10.1200/JCO.1989.7.3.381

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  10 in total

1.  Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma.

Authors:  Abeezar I Sarela; Thomas J Miner; Martin S Karpeh; Daniel G Coit; David P Jaques; Murray F Brennan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  Medical management of intestinal obstruction in terminal care.

Authors:  C Frank
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

Review 3.  Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  Sarah E Cousins; Emma Tempest; David J Feuer
Journal:  Cochrane Database Syst Rev       Date:  2016-01-04

4.  Management of bowel obstruction in patients with stage IV cancer: predictors of outcome after surgery.

Authors:  Valerie Francescutti; Austin Miller; Yashodhara Satchidanand; Amy Alvarez-Perez; Kelli Bullard Dunn
Journal:  Ann Surg Oncol       Date:  2012-09-19       Impact factor: 5.344

5.  Outcome of decompression using a transnasal ileus tube in malignant adhesive bowel obstruction: A retrospective study.

Authors:  Xiang-Jun Han; Fan Zhao; Hong-Ying Su; Ke Xu
Journal:  Mol Clin Oncol       Date:  2017-08-18

6.  Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation.

Authors:  Brian D Badgwell; Kerrington Smith; Ping Liu; Eduardo Bruera; Steven A Curley; Janice N Cormier
Journal:  Support Care Cancer       Date:  2008-12-13       Impact factor: 3.603

Review 7.  Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review.

Authors:  Terrah J Paul Olson; Carolyn Pinkerton; Karen J Brasel; Margaret L Schwarze
Journal:  JAMA Surg       Date:  2014-04       Impact factor: 14.766

8.  Small bowel obstruction in patients with a prior history of cancer: predictive findings of malignant origins.

Authors:  J Prost À la Denise; R Douard; G Malamut; F Mecheri; P Wind
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

9.  Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction.

Authors:  Jay Chouhan; Rohan Gupta; Joe Ensor; Kanwal Raghav; David Fogelman; Robert A Wolff; Michael Fisch; Michael J Overman
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452

10.  Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

Authors:  R B Veenhuizen; J P Marijnissen; P Kenemans; M C Ruevekamp-Helmers; L W 't Mannetje; T J Helmerhorst; F A Stewart
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.